Revenue - Narrative (Details) - USD ($) $ in Millions |
6 Months Ended | ||
|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
|
| Concentration Risk [Line Items] | |||
| Accounts receivable, net | $ 1,077 | $ 873 | |
| Product Sales | |||
| Concentration Risk [Line Items] | |||
| Accounts receivable, net | $ 131 | $ 107 | |
| Product Return Concentration Risk | Net revenue | Global Customers | |||
| Concentration Risk [Line Items] | |||
| Concentration risk | 1.00% | 1.00% | |
| Customer Concentration Risk | Revenue | Single Customer | |||
| Concentration Risk [Line Items] | |||
| Concentration risk | 12.00% | 12.00% | |
| X | ||||||||||
- Definition Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|